Company: HCTI
Filing Date: 2025-10-02
Form Type: PRE 14C
Source: 0001213900-25-095494
Chunk: 2

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-02
Form: PRE 14C
Chunk 2
---
ICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT</div>

No vote or other action by our shareholders is
required in response to this information statement. We are not asking you for a proxy and you are requested not to send us a proxy.

This Information Statement has been filed with
the Securities and Exchange Commission (“SEC”) and is being sent, pursuant to Section 14C of the Exchange Act, to the holders
of record as September 19, 2025 (the “Record Date”) of outstanding shares of common stock of Healthcare Triangle,
Inc., a Delaware corporation (“Healthcare Triangle,” the “Company,” “we,” “our,”
or “us”), to notify the shareholders that, on September 19, 2025, the Company received the written consent in lieu
of a meeting of stockholders from Suresh Venkatachari, the holder of 81.82% of the Company’s outstanding voting power (the “Majority Stockholder”), approving the the issuance of 1,388,041 shares of the Company’s restricted common stock (the “Acquisition Shares”) to Niyama Healthcare, Inc., a Delaware corporation and provider of Mental Health and Hospital Information Systems
technology, across India, South East Asia, and Europe (the “Seller”), pursuant to an Asst Transfer Agreement dated
June 16, 2025 and amended on August 28, 2025, as partial consideration for the acquisition (the “Acquisition”)
by the the Company of (i) all of the Seller’s assets related to its cloud and technology domain business and (ii) 100% of the equity
of interest in Ezovion Solutions Private Limited, a Hospital Information Systems SaaS Provider in Chennai, India. The other
consideration paid or payable by the Company includes: (1) $1.5 million in cash, of which $1.2 million was due at the closing of the
Acquisition and $300,000 to be paid at the later of the satisfaction of certain withholding requirements or within 120 days of the closing
and (2) up to $1.2 million in earn-out payments contingent on first-year financial performance targets to be agreed upon within 90 days
of the closing of the Acquisition.

As described more fully in this Information Statement,
stockholder approval of the issuance of the Acquisition Shares is required by Nasdaq Listing Rule 5635(a)(2). The Majority Stockholder
approved the issuance of the Acquisition Shares on September